Acute Acquired Demyelinating Polyneuropathy:An Initial Presentation of Diffuse Large B Cell Lymphoma

Acute Acquired Demyelinating Polyneuropathy:An Initial Presentation of Diffuse Large B Cell Lymphoma

Neurological signs and symptoms are commonly associated with both Hodgkin’s and non-Hodgkin’s lymphoma and are mostly attributed to either direct lymphomatous involvement of the nervous system, either as a result of extension to the spinal cord or nerves, or due to infiltration by lymphoma cells and...

Full description

Bibliographic Details
Main Authors:	Munira Shabbir-Moosajee, Ghulam Rehman Mohyuddin, Sara Khan, Ayeesha Kamran Kamal
Format:	Article
Language:	English
Published:	Shiraz University of Medical Sciences 2013-01-01
Series:	Middle East Journal of Cancer
Subjects:	Guillain-Barre syndrome Diffuse large B cell lymphoma Initial presentation Intravenous immunoglobulin
Online Access:	http://mejc.sums.ac.ir/index.php/mejc/article/view/141/222

Similar Items

Sodium Levels Predict Disability at Discharge in Guillain-Barré Syndrome: A Retrospective Cohort Study
by: Delia Gagliardi, et al.
Published: (2021-09-01)

The prognostic value of demyelinating electrophysiologic findings and cerebrospinal fluid protein levels in acute inflammatory demyelinating polyneuropathy
by: Abdulkadir TUNÇ, et al.
Published: (2020-08-01)

Prompt identification of loss of voice in a child can save a life, Guillian-Barre syndrome with vocal cord paralysis in a young boy
by: Kaushambi Basu, et al.
Published: (2021-01-01)

Pediatric Guillain-Barré syndrome: Indicators for a severe course
by: Muhammet Ali Varkal, et al.
Published: (2015-01-01)

Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré Syndrome
by: Erum Elahi, et al.
Published: (2019-12-01)

Acute sensory inflammatory demyelinating polyneuropathy and central diabetes insipidus
by: T. G. Sakovets, et al.
Published: (2021-04-01)

Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain-Barré syndrome (GBS) in patients with severe symptoms: A systematic review and meta-analysis
by: Hany A. Zaki, et al.
Published: (2023-06-01)

Clinical Follow-up of a Patient with Muscle Weakness During the Postoperative Intensive Care Period
by: Mustafa Deniz, et al.
Published: (2021-12-01)

Flaccid quadriparesis with raised creatine kinase in Guillain-Barré syndrome: a case report with review of literature
by: Bandari Mahesh, et al.
Published: (2021-12-01)

A Rare Case with New Insights: Pure Sensory Guillain Barre Syndrome with Axonal Features
by: Kofahi R, et al.
Published: (2020-10-01)

Factors predicting poor outcome in patients with fulminant Guillaine-Barré syndrome
by: Nandagopal Nithyashree, et al.
Published: (2014-01-01)

A young adult with leptospirosis associated acute inflammatory demyelinating polyneuropathy
by: Herman Bagula, et al.
Published: (2023-12-01)

Chronic inflammatory demyelinating polyneuropathy with an acute onset. Clinical case
by: Natalia A. Suponeva, et al.
Published: (2022-05-01)

Sensory Predominant Guillain-Barré Syndrome Concomitant with Dengue Infection: A Case Report
by: Alvin Oliver Payus, et al.
Published: (2022-06-01)

Guillain-Barré Syndrome Heralding the Diagnosis of Hodgkin Lymphoma: A Case Report
by: Alawi Aqel Al-Attas, et al.
Published: (2020-10-01)

Guillain–Barré syndrome occurring synchronously with systemic lupus erythematosus as initial manifestation treated successfully with low-dose cyclophosphamide
by: Naveed Ali, et al.
Published: (2016-04-01)

Guillain–Barré syndrome: the most common but difficult to diagnose acquired polyneuropathy
by: Majka Jaszczura, et al.
Published: (2018-10-01)

Guillain-Barre Syndrome Followed in the PICU; 3-year Experience
by: Halil Keskin, et al.
Published: (2021-06-01)

Experience of human normal immunoglobulin (Privigen, CSL BEHRING) administration in patients with Guillain - Barre syndrome in non-specialized neurological department
by: L. P. Smertina, et al.
Published: (2019-02-01)

Retrospective Analysis of Cases with Guillain-Barré Syndrome in Pediatric Intensive Care Unit
by: Hasan Serdar Kıhtır, et al.
Published: (2017-12-01)

Guillain-Barré Syndrome and Posterior Reversible Encephalopathy Syndrome following Spinal Surgery
by: Yui Sanpei, et al.
Published: (2019-09-01)

Intensive Care and Treatment of Severe Guillain–Barré Syndrome
by: Pei Shang, et al.
Published: (2021-04-01)

Síndrome de Guillain-Barré com flutuações relacionadas ao tratamento com imunoglobulina humana endovenosa (curso trifásico): relato de caso Fluctuations in Guillain-Barré syndrome related to treatment with intravenous human immunoglobulin (trifasic course): case report
by: MÁRIO EMÍLIO DOURADO, et al.
Published: (1998-09-01)

Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus
by: Farzad Fatehi, et al.
Published: (2013-01-01)

Acute inflammatory demyelinating polyneuropathy or Guillain-Barré syndrome associated with COVID-19: a case report
by: Dmitriy A. Gagarkin, et al.
Published: (2021-04-01)

Guillain-Barré Syndrome as First Presentation of Non-Hodgkin's Lymphoma
by: Abolhassan Ertiaei, et al.
Published: (2016-07-01)

A Severe Course of Relapsing-Remitting Acute-Onset Chronic Inflammatory Demyelinating Polyneuropathy in a Young Man
by: Anna P. Patnaik, et al.
Published: (2021-02-01)

Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: A Historical Perspective
by: Dario Cocito, et al.
Published: (2023-11-01)

Guillain–Barre syndrome: small-volume plasmapheresis versus intravenous immunoglobulin—3rd level hospital experience
by: Khaoula Balili, et al.
Published: (2024-03-01)

Dengue-induced Guillain–Barre syndrome: a case series
by: Hina Imtiaz, et al.
Published: (2023-11-01)

Clinical applications of immunoglobulin: update
by: Marcia Cristina Zago Novaretti, et al.
Published: (2011-06-01)

Axonal excitability findings in acute inflammatory demyelinating polyneuropathy related to SARS-CoV-2
by: Abir Alaamel, et al.
Published: (2022-01-01)

CLINICAL PRESENTATIONS AND COMPLICATIONS OF GUILLAIN BARRE SYNDROME IN CHILDREN WELFARE TEACHING HOSPITAL
by: Mahjoob N. Al-Nadawi, et al.
Published: (2016-12-01)

Nerve Ultrasound Score in Chronic Inflammatory Demyelinating Polyneuropathy
by: Cheng-Yin Tan, et al.
Published: (2023-04-01)

Guillain–Barré syndrome after allogeneic bone marrow transplantation: Case report and literature review
by: Tomoko Yoshida, MD, et al.
Published: (2016-09-01)

Intravenous immunoglobulin vs plasma exchange in treatment of mechanically ventilated adults with Guillain-Barré syndrome
by: Boubaker Charra, et al.
Published: (2014-05-01)

Clinical Outcome of Intravenous Immunoglobulin in the treatment of Guillain Barre Syndrome in a Nepalese Tertiary Centre
by: Rajeev Ojha, et al.
Published: (2019-06-01)

Management of Guillain-Barré Syndrome
by: Kadarapura N. Gopalakrishna, et al.
Published: (2019-06-01)

High doses of immunoglobulin g in the therapy for severe forms of myasthenia gravis and Guillain-Barré syndrome
by: Lavrnić Dragana, et al.
Published: (2006-01-01)

Hymenoptera sting as atypical causative factor for Guillain Barré Syndrome and chronic inflammatory demyelinating polyneuropathy – A case report and insights on pathophysiology
by: Cristina Gatcan, et al.
Published: (2023-12-01)